- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06364644
Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure (UNLOAD-HF)
Understanding and Addressing Risks of Low Socioeconomic Status and Diabetes for Heart Failure (UNLOAD-Heart Failure)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This randomized controlled trial employs a 2:1 allocation ratio. The study aims to include 402 individuals from Baltimore City and Hagerstown, Maryland, characterized by low neighborhood and individual socioeconomic status, type 2 diabetes, obesity, and evidence of subclinical heart dysfunction, without a prior clinical diagnosis of heart failure. The 6-month multi-level intervention consists of three key components:
- Problem Solving - Diabetes Self-Management Training (DECIDE): Participants will engage in a biweekly evidence-based behavioral change program known as DECIDE. This program focuses on problem-solving training, aiding individuals in managing chronic conditions by overcoming obstacles and challenges. It aims to enhance self-care, improve control of metabolic risk factors, and includes tailored education on heart failure prevention.
Community Health Worker Support: Participants will receive ongoing support from community health workers as part of the intervention. These workers will conduct telephone and/or home visits at least monthly, offering assistance in following areas:
- Reinforcing patient education about disease self-management
- Helping patients access care and addressing barriers to care and treatment
- Serving as facilitators and navigators to clinical care, social services, and other community resources
- Providing encouragement and support to engage, activate, and empower patients and their support systems
- Health Coaching and Partnership with Community Facilities: Participants will engage in supervised aerobic and resistance exercise training at the local Young Men's Christian Associations (YMCAs). The participants will receive instructions on gradually increasing the activity levels throughout the 6-month intervention to achieve physical activity goals (150 minutes of moderate to vigorous exercise per week).
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Chiadi Ndumele, MD, PhD
- Phone Number: 4105022319
- Email: cndumel2@jhmi.edu
Study Contact Backup
- Name: Perri Carroll, MPH
- Phone Number: 4436927272
- Email: pcarro13@jhmi.edu
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21205
- Recruiting
- Johns Hopkins Center for Health Equity
-
Contact:
- Perri Carroll, MPH
- Phone Number: 443-692-7272
- Email: pcarro13@jhmi.edu
-
Hagerstown, Maryland, United States, 21740
- Not yet recruiting
- Johns Hopkins University Comstock Center
-
Contact:
- Melissa Minotti, MPH, RPSGT, CCRC
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults from Johns Hopkins Medicine (JHM) who live in Baltimore City and adults from Johns Hopkins Community Physicians (JHCP) Hagerstown or Family Healthcare of Hagerstown who live in Washington County
- Low socioeconomic status (SES) by high Area Deprivation Index (ADI) [>75th percentile for the state of Maryland] plus low income)
- Type 2 diabetes
- Obesity (BMI≥30 kg/m^2)
Exclusion Criteria:
- Age < 30 or >70 years
- Prevalent heart failure
- Uncontrolled glycemia (blood glucose <60 mg/d or ≥ 300 mg/dl or most recent hemoglobin A1c ≥11%)
- Uncontrolled blood pressure (Systolic blood pressure (SBP) ≥160 or diastolic blood pressure (DBP) ≥100 mm Hg, either on or off medications)
- Known coronary artery disease (unless < 50% stenosis by angiography)
- Moderate or severe valvular heart disease
- Serious medical conditions limiting life expectancy or requiring active management
- Inability to participate in moderate intensity physical activity as assessed by the self-report Physical Activity Readiness Questionnaire Plus (PAR-Q+).
- Any condition or planned surgery/procedure precluding exercise for ≥ 150 minutes per week
- End-stage renal disease
- Current participation in another behavior change program
- Active alcohol or substance abuse disorder
- Already engaging in regular exercise with more than 60 minutes of moderate [3-6 METS] to vigorous [>6 METS] physical activity per week
- Active pregnancy
- Evidence of ischemia, dangerous arrhythmia, or other clinical instability on baseline exercise stress test
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Community Champions
Participants assigned to the "Community Champions" group will undergo a six-month behavioral intervention.
This intervention involves bi-weekly problem-solving training sessions (DECIDE) conducted in groups of 6-10 individuals, along with support from community health workers.
Additionally, participants will receive a YMCA membership to exercise with a professional health coach.
|
The UNLOAD-Heart Failure Program intervention includes problem solving training, community health worker support, and exercise support from health coaches at YMCAs.
Other Names:
|
|
Active Comparator: Homegrown Heroes
Participants assigned to the "Homegrown Heroes" will receive a YMCA membership for exercise and a monthly newsletters for 6 months that include education about diabetes self-management, healthy lifestyle and heart failure prevention .
|
Monthly newsletters/videos on diabetes self-management, healthy lifestyle and heart failure prevention will be provided, as well as a membership to the local YMCA.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in fitness as assessed by the 6 minute walk test
Time Frame: Baseline and 6 month follow up
|
Total distance walked in the 6 minutes walk test in meters
|
Baseline and 6 month follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in hemoglobin A1c
Time Frame: Baseline and 6 month follow up
|
Absolute change from baseline in hemoglobin A1c
|
Baseline and 6 month follow up
|
|
Change in specific problem solving skills as assessed by Health Problem-Solving Scale (HPSS) subscales.
Time Frame: Baseline, 6 month follow up, 12 month follow up
|
The following Health Problem-Solving Scale (HPSS) subscales will be assessed: Impulsive/Careless Problem Solving (IPS), Avoidant Problem Solving (APS), Negative Transfer (NTR), Negative Motivation/Orientation (NMO).
Subscale scores are calculated by summing the scores for each item within the respective subscales.
Higher subscale scores indicate more of that problem-solving characteristic.
The score range for each subscale is as follows: IPS (0-32), APS (0-28), NTR (0-44), NMO (0-20).
Total score range 0-124.
|
Baseline, 6 month follow up, 12 month follow up
|
|
Changes in self care measures as assessed by Summary of Diabetes Self-Care Activities Scale (SDSCA)
Time Frame: Baseline, 6 month follow up, 12 month follow up
|
The Summary of Diabetes Self-Care Activities Scale (SDSCA) is a tool used to measure diabetes self-care activities.
12-items with 5 sub-scales (diet, exercise, home blood glucose testing, foot care, smoking status).
The respondent is asked how many days in the past week the behavior was performed (ranges from 0 to 7); The result is an average score between 0 and 7 with higher score indicating better diabetes self-management behavior.
|
Baseline, 6 month follow up, 12 month follow up
|
|
Changes in disease knowledge as assessed by Diabetes and Cardiovascular Disease (CVD) Knowledge Test
Time Frame: Baseline, 6 month follow up, 12 month follow up
|
The Diabetes and CVD Knowledge Test comprises 16 items, featuring both multiple-choice and true-or-false questions.
This assessment tool gauges individuals' comprehension of diabetes, its impact on health, and optimal strategies for managing the condition.
The possible score range is 0-17.
A higher score indicates a better understanding of diabetes and cardiovascular disease.
|
Baseline, 6 month follow up, 12 month follow up
|
|
Changes in physical activity as assessed by Modified Physical Activity Questionnaire (MPAQ)
Time Frame: Baseline, 6 month follow up, 12 month follow up
|
The MPAQ is a tool used to estimate the frequency in days (number of times per month) and in time (minutes) someone participated in physical activity (e.g. biking, walking, swimming, etc.). Hours per week for all activities are summed to determine activity hours per week averaged over the past year. A higher sum indicates more physical activity. Values can also be weighted by their estimated metabolic cost and expressed as metabolic equivalent (MET) hours per week. Higher METs are associated with better outcomes. The MPAQ also assesses inactivity, such as the average number of hours per day spent watching television or being confined to a bed or chair for more than 1 week. A higher average indicates less physical activity. |
Baseline, 6 month follow up, 12 month follow up
|
|
Change in weight (kgs)
Time Frame: Baseline and 6 month follow-up
|
Change from baseline in weight (kgs)
|
Baseline and 6 month follow-up
|
|
Change in BMI
Time Frame: Baseline and 6 month follow-up
|
Change from baseline in BMI (Kg/m^2).
|
Baseline and 6 month follow-up
|
|
Change in hip and waist circumference (centimeters)
Time Frame: Baseline and 6 month follow up
|
Change from baseline in hip and waist circumference (centimeters)
|
Baseline and 6 month follow up
|
|
Change in Metabolic Syndrome Severity Z score
Time Frame: Baseline and 6 month follow up
|
Metabolic Syndrome Severity (MetS) Z score calculates an individual's metabolic syndrome severity score by examining five key markers: waist circumference, blood pressure, triglycerides, HDL, and fasting glucose.
Score typically ranges from -5 to 5. Higher scores indicate greater metabolic syndrome severity.
|
Baseline and 6 month follow up
|
|
Change in self-management as assessed by the Patient Activation Measure (PAM-13).
Time Frame: Baseline, 6 month follow up,12 month follow up
|
The Patient Activation Measure is a 13-item survey that will assess an individual's knowledge, skills and confidence to managing one's health and healthcare.
The PAM scores is calculated and then transformed to a scale with a range from 0-100.
A higher PAM score indicates higher patient activation.
The score can also be converted into four activation levels: 1 - not believing activation important, 2 - lack of knowledge and confidence to take action, 3 - beginning to take action, 4 - taking action.
|
Baseline, 6 month follow up,12 month follow up
|
|
Change in quality of life and overall health and well-being as assessed by the Patient-Reported Outcomes Measurement Information System (PROMIS) Global Health 10
Time Frame: Baseline, 6 month follow up,12 month follow up
|
The PROMIS Global Health 10 survey comprises 10 items designed to evaluate both physical and mental health status.
Scores are aggregated separately for physical and mental health, each ranging from 4 - 20.
Higher scores in both categories indicate better outcomes.
|
Baseline, 6 month follow up,12 month follow up
|
|
Change in blood pressure (systolic and diastolic (mmHg))
Time Frame: Baseline and 6 month follow up
|
changes in blood pressure from baseline
|
Baseline and 6 month follow up
|
|
Change in cardiac biomarker, gal-3
Time Frame: Baseline and 6 month follow up
|
Percent change from baseline in gal-3
|
Baseline and 6 month follow up
|
|
Change in cardiac biomarkers, NT-proBNP
Time Frame: Baseline and 6 month follow up
|
Percent change from baseline in NT-proBNP
|
Baseline and 6 month follow up
|
|
Change in cardiac biomarker, high-sensitivity cardiac troponin-T (hs-cTnT)
Time Frame: Baseline and 6 month follow up
|
Percent change from baseline in hs-cTnT
|
Baseline and 6 month follow up
|
|
Change in post-walk Borg dyspnea scale
Time Frame: Baseline and 6 month follow up
|
Changes in post-walk Borg dyspnea scale which ranges from 0 ("no shortness of breath") to 10 ("worst possible shortness of breath"); higher score worse breathing difficulty.
Measured in a subset of the population.
|
Baseline and 6 month follow up
|
|
Change in cardiorespiratory fitness as assessed by peak oxygen uptake (V02 peak)
Time Frame: Baseline and 6 month follow up
|
Change in peak oxygen uptake (VO2 peak) as assessed by a cardiopulmonary fitness test in a subset of the population.
|
Baseline and 6 month follow up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Chiadi Ndumele, MD, PhD, Johns Hopkins School of Medicine
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Endocrine System Diseases
- Cardiovascular Diseases
- Nutrition Disorders
- Heart Diseases
- Metabolic Diseases
- Overnutrition
- Body Weight
- Glucose Metabolism Disorders
- Overweight
- Pathological Conditions, Signs and Symptoms
- Behavior
- Nutritional and Metabolic Diseases
- Signs and Symptoms
- Heart Failure
- Obesity
- Diabetes Mellitus
- Motor Activity
- Socioeconomic Factors
- Population Characteristics
- Educational Status
Other Study ID Numbers
- IRB00336599
- 1P50MD017348-01 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Heart Failure
-
Indiana UniversityRecruitingCongestive Heart Failure | Congestive Heart Failure (CHF) | Congestive Heart Failure Chronic | Congestive Heart Failure(CHF)United States
-
University of Health Sciences LahoreRecruitingAcute Decompensated Heart Failure | Heart Failure, Diastolic | Heart Failure, SystolicPakistan
-
Tufts Medical CenterMetro West Medical CenterCompletedCongestive Heart Failure | Diastolic Heart Failure | Systolic Heart FailureUnited States
-
Abbott Medical DevicesCompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure NYHA Class II | Heart Failure NYHA Class III | Heart Failure With Reduced Ejection Fraction | Heart Failure NYHA Class IV | Heart Failure With Normal Ejection Fraction | Heart Failure; With Decompensation | Heart Failure...United States, Canada
-
Manipal UniversityUnknownHeart Failure | Decompensated Heart Failure | Acute Heart Failure | Diastolic Heart Failure | Systolic Heart FailureIndia
-
Lakeland Regional Health Systems, Inc.RecruitingHeart Failure | Heart Failure Acute | Acute Heart Failure (AHF) | Heart Failure - NYHA II - IVUnited States
-
VA Eastern Colorado Health Care SystemNational Institute on Aging (NIA)CompletedHeart Failure | Heart Failure, Diastolic | Heart Failure, Systolic | Heart Failure With Reduced Ejection Fraction | Heart Failure With Preserved Ejection Fraction | Heart Failure; With Decompensation | Heart Failure,Congestive | Heart Failure AcuteUnited States
-
Eli Lilly and CompanyNot yet recruitingHeart Failure | Heart Failure, Diastolic | Heart Failure, SystolicUnited States, Japan
-
Wake Forest UniversityCompletedHeart Failure, Congestive | Heart Failure With Preserved Ejection Fraction
-
Wake Forest UniversityNational Institute on Aging (NIA)CompletedHeart Failure, Congestive | Diastolic Heart FailureUnited States
Clinical Trials on Community Champions
-
Johns Hopkins Bloomberg School of Public HealthNational Institute of Mental Health (NIMH); Community Media Trust; TB HIV CareCompletedHIV Infections | Pre-exposure ProphylaxisSouth Africa
-
Centre for Chronic Disease Control, IndiaKathmandu Medical College and Teaching Hospital; All India Institute of Medical...Not yet recruitingEndocrine, Nutritional and Metabolic Diseases | Diseases of the Eye and Adnexa | Diseases of the Ear and Mastoid Process | Diseases of the Circulatory System | Diseases of the Respiratory System | Diseases of the Musculoskeletal System and Connective Tissue | Mental, Behavioral and Neurodevelopmental...India, Nepal
-
University of DodomaStephen Kibusi; James Tumaini KengiaNot yet recruitingObstetric Complication | Woman's RoleTanzania
-
Midwest Evaluation & ResearchAnthem Strong FamiliesCompleted
-
Virginia Commonwealth UniversityTerminated
-
University of Maryland, BaltimoreUniversity of Southern California; Cornell University; United States Department... and other collaboratorsCompleted
-
University of WashingtonNational Institute of Nursing Research (NINR)CompletedAny Disease Causing Death in the ICU or Within 24 Hours of Discharge From the ICUUnited States
-
King's College LondonSouth London and Maudsley NHS Foundation TrustUnknownSchizophrenia | Bipolar Disorder | Major Depressive DisorderUnited Kingdom
-
Centre for Chronic Disease Control, IndiaUniversity of Leicester; Kathmandu Medical College and Teaching Hospital; All...Not yet recruitingChronic Conditions, Multiple | Endocrine, Nutritional and Metabolic Diseases | Diseases of the Eye and Adnexa | Diseases of the Ear and Mastoid Process | Diseases of the Circulatory System | Diseases of the Respiratory System | Diseases of the Musculoskeletal System and Connective Tissue | Mental...India, Nepal
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedStress | Burnout | Stress, Psychological | Stress, Emotional | Maternal Health | Mental Health | Quality of Care | Discrimination, Social | Adverse Outcomes | Healthcare ProviderKenya